São Paulo School of Advanced Science on Medicines: from Target to Market


The 10th Summer School on Medicines (SSM10) will be held in Ribeirão Preto, SP, Brazil from March 16 – 23, 2018, under the sponsorship of the Sao Paulo School of Advanced Science initiative (FAPESP, the São Paulo Research Foundation).

SSM10 is structured to cover the whole process that leads from ideas and projects to drugs reaching the market, with interactive classes, case studies, lecture sessions and visits to the SUPERA Tech Park.

SSM10 offers a unique 50-hour training program on drug discovery, development and market access under a multicultural sponsorship in the nice setting of Ribeirão Preto city, SP, Brazi.

The Faculty members are leaders in their field and contribute to create one of the most innovative and focused programs in drug discovery and development currently offered.

  • Institution

    Faculdade de Medicina de Ribeirão Preto - FMRP/USP

  • Field of Knowledge

    Medicine

  • Academic Director

    Claudio Miguel da Costa Neto

  • Grant Number

    2017/17382-4

  • Date

    2018-03-16 to 2018-03-23

  • Registration Deadline

    closed

  • Site

    http://summerschoolonmedicines10.fmrp.usp.br/

  • City

    Ribeirão Preto

  • Keywords

  • Program Hide

    PRELIMINARY PROGRAM:

    FRIDAY, March 16th – 2018

    Venue: Ribeirão Preto Medical School, University of São Paulo (FMRP/USP).

    REGISTRATION, KEYNOTE LECTURES, AND POSTER PRESENTATION

    14:00 – 16:00 Registration & Poster placing

    16:00 – 16:15 OFFICIAL OPENING

    Chair: The Organizing Committee

    16:15 – 17:15 Keynote Opening Lecture 1 (KNL1)
    *T.B.A.

    17:15 – 18:00 Keynote Opening Lecture 2 (KNL2)
    Carlos Henrique de Brito Cruz, Scientific Director of FAPESP, Sao Paulo, Brazil.

    18:00 – 20:00 Welcome Reception with Poster presentations from students

    SATURDAY, March 17th – 2018

    Venue: Ribeirão Preto Medical School, University of São Paulo (FMRP/USP).

    SESSION I: DRUG R&D, AN OVERVIEW FROM IDEA TO MARKET

    Chairperson: Jordi Quintana & Claudio Costa-Neto

    09:00 – 09:45 (L1) Drug Discovery overview: from idea to drug candidate

    Denis deBlois, Pharmacy Faculty Director, University of Montreal, Canada.

    09:45 – 10:30 (L2) Overview on Clinical trials

    Denis deBlois, Pharmacy Faculty Director, University of Montreal, Canada.

    10:30 – 11:00 Coffee Break

    11:00 – 12:00 (L3) Overview on Business Development

    Steven Xanthoudakis, Merck Frosst Centre for Therapeutic Research in Montreal, Canada.

    12:00 – 14:00 Lunch

    SESSION II: TARGET-BASED DRUG DISCOVERY

    Chairperson: Jordi Quintana & Claudio Costa-Neto

    14:00 – 15:00 (L4) Chemical biology for Drug-Discovery

    Jordi Quintana, Barcelona Scientific and Technological Park, Barcelona, Spain.

    15:00 – 16:00 (L5) From basic to updated concepts in Drug-Discovery Pharmacology

    André S. Pupo, State University of Sao Paulo, UNESP, Botucatu, SP, Brazil

    16:00 – 16:30 Coffee Break

    16:30 – 17:15 (L6) Drug Design based on target structure

    Xavier Deupi, Paul Scherrer Institute, Switzerland

    17:15 – 18:00 (L7) Hands on: structure analysis and drug/target modeling

    Xavier Deupi, Paul Scherrer Institute, Switzerland

    18:00 – 19:00 Poster Discussion

    SUNDAY, March 18th – 2018

    Venue: Ribeirão Preto Medical School, University of São Paulo (FMRP/USP).

    SESSION III: ORAL PRESENTATIONS FROM STUDENTS

    09:00 – 10:30 Oral Presentations from Students

    10:30 – 11:00 Coffee Break

    SESSION IV: FROM DRUG DISCOVERY TO EARLY (PRE)CLINICAL DEVELOPMENT (PART I)

    Chairperson: Denis DeBlois, Pierre Cordelier

    11:00 – 12:00 (L8) ADME (Pharmacokinetics / Pharmacodynamics)

    *T.B.A.

    12:00 – 14:00 Lunch

    14:00 – 15:00 (L9) New classes of biological drugs: cell and gene therapy products

    Pierre Cordelier, INSERM U1037, Toulouse Oncopole & University Paul Sabatier, Toulouse, France.

    15:00 – 16:00 (L10) Drug Discovery of dendrimers: from discovery to creation of a startup

    Rémy Poupot, CHU Purpan, University Paul Sabatier, Toulouse, France

    16:00 – 16:30 Coffee Break

    16:30 – 17:15 (L11)

    *T.B.A.

    17:15 – 18:00 (L12) Discovery and development of new GPCR biased drugs

    Claudio Costa-Neto, Ribeirao Preto Medical School, USP

    18:00 – 19:00 Poster Discussion

    MONDAY, March 19th – 2018

    Venue: SUPERA Technological Park.

    SESSION V: CASE STUDY IN DRUG DISCOVERY AND DEVELOPMENT

    Chairperson: Denis DeBlois, Rémy Poupot, Pierre Cordelier

    09:00 – 09:30 Case presentation and outline of challenges

    09:30 – 10:30 Group session (students work in small teams)

    10:30 – 11:00 Coffee Break

    11:00 – 12:30 Each team reports / General discussion

    12:30 – 14:00 Lunch

    SESSION VI: FROM DRUG DISCOVERY TO EARLY (PRE)CLINICAL DEVELOPMENT (PART II)

    Chairperson: Roger Chammas (School of Medicine, University of Sao Paulo)

    14:00 – 15:00 (L13) Toxicology / Preclinical Safety

    Denis deBlois, Pharmacy Faculty Director, University of Montreal, Canada

    15:00 – 16:00 (L14) Pre-Clinical Development

    Pierre Cordelier , INSERM U1037, Toulouse Oncopole & University Paul Sabatier, Toulouse, France

    16:00 – 16:30 Coffee Break

    16:00 – 18:00 Visit SUPERA Technological Park

    TUESDAY, March 20th – 2018

    Venue: Ribeirão Preto Medical School, University of São Paulo (FMRP/USP).

    SESSION VII: FROM DRUG DISCOVERY TO EARLY (PRE)CLINICAL DEVELOPMENT (PART III)

    09:00 – 09:45 (L15) Illustrative cases presented by an entrepreneur (I): From discovery to pharmaceutical development

    Invited Speaker: Robson A. S. Santos, Professor at UFMG and founder of Labfar, Belo Horizone, MG, Brazil.

    09:45 – 10:30 (L16) Learning and confirming trials

    Mark Kester, University of Virginia, USA

    10:30 – 11:00 Coffee Break

    11:00 – 12:00 (L17) Illustrative cases presented by an entrepreneur (II): Medical Devices

    Invited Speaker: Jarbas Caiado de Castro Neto, Professor at USP/São Carlos and founder of Opto

    12:00 – 14:00 Lunch

    14:00 – 15:00 (L18) Regulatory agencies

    *T.B.A.

    15:00 – 18:00 Visit Laboratories at University of Sao Paulo Campus

    WEDNESDAY, March 21st – 2018

    Venue: Ribeirão Preto Medical School, University of São Paulo (FMRP/USP).

    SESSION VIII: CLINICAL DEVELOPMENT & REGULATORY

    Chairperson: Denis DeBlois

    09.00 – 9:45 (L19) Clinical Phases

    *T.B.A.

    9:45 – 10:30 (L20) Benefit/risk assessment / Pharmacovigilance

    Denis deBlois, Pharmacy Faculty Director, University of Montreal, Canada
    10:30 – 11:00 Coffee Break

    11:00 – 11:45 (L21) Market access

    *T.B.A.

    11:45 – 12:30 (L22) “Beyond the pill”: Gene Editing and Ethical Concerns

    Pierre Cordelier, INSERM U1037, Toulouse Oncopole & University Paul Sabatier, Toulouse, France

    12:30 – 14:00 Lunch

    SESSION IX: PHARMACO ECONOMICS & INTELLECTUAL PROPERTY

    Chairperson: Jordi Quintana

    14:00 – 15:00 (L23) Pharmaco-economics

    *T.B.A.

    15:00 – 16:00 (L24) Intellectual Property

    *T.B.A.

    16:00 – 16:30 Coffee Break

    16:30 – 18:00 Visit Laboratories at University of Sao Paulo Campus

    THURSDAY, March 22nd – 2018

    Venue: Ribeirão Preto Medical School, University of São Paulo (FMRP/USP).

    SESSION X: START-UP CREATION, INVESTMENT & BUSINESS DEVELOPMENT

    Chairperson: Jordi Quintana & Claudio Costa-Neto

    09:00 – 09:45 (L25) Public-Private Partnership for Drug Discovery and Development

    Jordi Quintana, Barcelona Scientific and Technological Park, Barcelona, Spain; and Steven Xanthoudakis, Merck Frosst Centre for Therapeutic Research in Montreal, Canada.

    09:45 – 10:30 (L26) Start-up Creation

    Mark Kester, University of Virginia, USA

    10:30 – 11:00 Coffee Break

    11:00 – 12:00 (L27) Illustrative cases presented by an entrepreneur (III): Venture Capital Investment in Brazil

    Invited Speaker: Fernando Reinach, former Professor at USP and founder of Fundo Pitanga (Venture Capital Fund)

    12:30 – 14:00 Lunch

    SESSION XI: CASE STUDY IN INTELLECTUAL PROPERTY

    Chairperson: Jordi Quintana, Rémy Poupot, Pierre Cordelier

    14:00 – 15:30 Case presentation and outline of challenges

    14:30 – 16:00 Group session (students work in small teams)

    16:00 – 16:30 Coffee Break

    16:30 – 18:00 Each team reports / General discussion

    FRIDAY, March 23rd – 2018

    Venue: Ribeirão Preto Medical School, University of São Paulo (FMRP/USP).

    SESSION XII: CAREERS & PERSPECTIVES IN LIFE SCIENCES

    09:00 – 10:30 (L28) Careers in Life Sciences (Panel)

    The Organizing Committee & Invited Speakers.

    10:30 – 11:00 Coffee Break

    11:00 – 12:00 (L29) Broadening the horizons: Systems Biology as an approach to identify problems and possible solutions

    Helder Nakaya, Faculty of Pharmaceutical Sciences, USP, São Paulo.

    12:00 – 14:00 Lunch

    SESSION XIII: CLOSING SESSION

    Chair: The Organizing Committee

    14:00 – 15:00 (KNL3) – Keynote Closing Lecture 3. Illustrative cases presented by an entrepreneur (IV): Foundation and development of Recepta Biopharma

    Invited Speaker: Fernando Perez, former Professor at USP and founder of Recepta Biopharma.

    15:00 – 16:00 (KNL4) – Keynote Closing Lecture 4.

    Michel Bouvier, Department of Biochemistry, Institute for Research in Immunology and Cancer (IRIC), University of Montreal, Canada.

    16:00 – 16:15 SSM10 Evaluation / Final Discussion

    16:15 – 16:30 SSM10 closing remarks and pre-launching of SSM11 in Montreal, Canada.

    16:30 – 17:00 Farewell Coffee Break

Back